Distichiasis (DIS)
Gene or Region: chr13:178714-195130
Reference Variant: No deletion
Mutant Variant: 16kb deletion on chromosome 13
Affected Breeds: Friesian
Research Confidence: High - Strong association in studied population
Explanation of Results: dis/dis = homozygous for Distichiasis, increased chance of trait expressed dis/n = heterozygous for Distichiasis, carrier n/n = no variant detected
Distichiasis in Friesians: Genetic Testing & Insights
Distichiasis is a condition in which abnormal eyelashes—called distichia—emerge from the Meibomian glands along the eyelid margin. These glands normally produce a part of the tear film, not hair. When distichia are present, they may come into contact with the surface of the eye (the cornea), leading to irritation, excessive tearing, squinting, or, in more severe cases, corneal ulcers and vision loss. While some horses show clear signs of discomfort, others may have no symptoms at all, making the condition easy to overlook without a thorough exam.
Distichiasis is inherited as an autosomal recessive trait with incomplete penetrance—meaning a horse must have two copies of the variant (Dis/Dis) to be at risk, but not all will show signs of disease. For Friesians with this genotype, regular eye exams by a veterinary ophthalmologist are recommended to monitor for aberrant lashes or vision-threatening changes.
Gene Information
Researchers have identified a 16-kilobase (kb) deletion on chromosome 13 (ECA13:g.178714_195130del) associated with this disorder. This deletion is located between the FAM20C and PDGFA genes and is believed to affect a regulatory region of the genome, though the exact mechanism leading to Distichiasis remains under investigation. Genetic testing is available to detect this variant, aiding in breeding decisions and early clinical interventions to manage or prevent the condition. Distichiasis has also been found in other breeds not related to Friesians. Further research is needed to determine the frequency and effect in other breeds.
NOTE: This variant has been seen in other breeds at very low levels, and all horses were carriers. In breeds other than Friesians it is currently unclear if this variant is causing Distichiasis. More research is needed for these breeds.
References
Hisey, E.A., Hermans, H., Lounsberry, Z.T., Avila, F., Grahn, R.A., Knickelbein, K.E., Duward-Akhurst, S.A., McCue, M.E., Kalbfleisch, T., Lassaline, M.E., Back, W., & Bellone, R.R. (2020). Whole genome sequencing identified a 16 kilobase deletion on ECA13 associated with distichiasis in Friesian horses. BMC Genomics, 21, 848. doi: 10.1186/s12864-020-07265-8
More Horse Health
Glanzmann Thrombasthenia
Glanzmann Thrombasthenia (GT) is a blood platelet function disorder, resulting from a reduction in the platelet fibrinogen receptor protein. Clinical signs can be characterized by bleeding on the skin or from the mouth/nostril/gastrointestinal mucosas, and may include skin rashes with blood spots under the skin, nasal bleeding, gastrointestinal and gingival bleedings.
Glycogen Branching Enzyme Deficiency
Glycogen Branching Enzyme Deficiency (GBED) is a lethal recessive disorder characterized by seizures, muscle weakness, respiratory failure, and death. Many affected foals do not make it full term and are aborted or stillborn. Carriers (gbed/n) have no known issues.
Hereditary Equine Regional Dermal Asthenia
Hereditary Equine Regional Dermal Asthenia (HERDA) is a degenerative skin disease that primarily affects the American Quarter Horse. Loose skin is often an early indication of the disease, and severe seromas, hematomas, ulcerations usually develop around 1.5 years of age. There is no cure, and the majority of affected animals have to be euthanized within 2-4 years.